COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special populations. Topics include transmission and pathogenesis, diagnosis and treatment, drug resistance, TB-HIV co-infection, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.
AGENDA
WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:
- Community Health Settings
- TB Programs
- Health Departments
- Hospital Infection Control
- Correctional Facilities
- Long Term Care Facilities
- Immigrant & Refugee Health
- College or University Health Services
WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.
OBJECTIVES
Upon completion of this workshop, participants should be better able to:
- List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.
- Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
- Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
- Integrate current recommendations for the prevention and management of tuberculosis in children and adolescents.
- Develop strategies for the care of TB patients with co-morbidities to ensure prompt diagnosis, integrated treatment, and effective management.
- Apply the latest advances for assessing risk, testing and treating TB infection to prevent development of disease.
COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 1 month of the course.
CONTINUING EDUCATION INFORMATION
In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 16.00 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.
REGISTRATION INFORMATION
Register for 1 day-Focus on LTBI (July 16 only): Fee $50
Apply for full 3-day TB Intensive Workshop (July 16-18): Fee $120
The registration deadline is June 14, 2019. Notification of acceptance, payment information and additional course information will be sent via email with 10 days of registraiton. The fee for the course will be collected following acceptance and registraiton. For application and registration questions please contact Kathryn Wilton at 517-284-9625 or email MDHHS-TSTworkshop@michigan.gov.
DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.
CANCELLATION INFORMATION
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated. Substitutions are welcome; refunds can only be issued for cancellations received by July 9, 2019. Please email cancellations to MDHHS-TSTworkshop@michigan.gov.
FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.